Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I)
Chemical Name: 5-[6-(3-methoxyoxetan-3-yl)-7-methyl-4-(morpholin-4-yl)thieno[3
0000000000000409
though it may also have an anti-angiogenic effect
SN-38 Size:Solid 2 mg Pantothenic acid decreases valproic acid-inducedSN 38 is the active metabolite of irinotecan (an analog of camptothecin a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN 38 relative to irinotecan varies from 2 to 2000 fold. SN38 is metabolized via glucoronidation by UGT1A1. The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolization of irinotecan predicts irinotecan toxicity, as it cannot be